Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Ampio Pharmaceuticals Inc (EM) AMPE

Healthcare Biotechnology
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

Current News (EXPM:AMPE)

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

PR Newswire April 3, 2024

Ampio Announces Voluntary Delisting and SEC Deregistration

PR Newswire March 25, 2024

Ampio Provides Update on Results from Pre-IND Enabling Studies

PR Newswire February 14, 2024

Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions

PR Newswire January 11, 2024

Ampio Pharmaceuticals to Present at the Emerging Growth Conference

PR Newswire October 31, 2023

Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201

PR Newswire October 5, 2023

Ampio Pharmaceuticals to Present at the Emerging Growth Conference

PR Newswire September 26, 2023

Ampio Pharmaceuticals Announces Reverse Stock Split

PR Newswire August 31, 2023

Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

PR Newswire May 26, 2023
View More News ››

Opinion & Analysis (EXPM:AMPE)

FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients

Streetwise Reports June 22, 2020
View More Opinion ››

Bullboard Posts (EXPM:AMPE)

Ampio Pharmaceuticals, Inc. (AMPE): A Promising Osteoarthrit

http://beyondspx.com/2024/08/02/ampio-pharmaceuticals-inc-ampe-a-promising-osteoarthritis-treatment-in-the-pipeline-but-significant...
MikeTester - August 3, 2024

AMPE....Surprise...Surprise !

Ampio Announces Voluntary Delisting and SEC Deregistration 2024-03-25 14:00 ET - News Release ENGLEWOOD, Colo.
Iseneschal - March 26, 2024

AMPE .....Huge pop up !!!!

I sold way too early....Again !!!!
Iseneschal - November 30, 2023

AMPE....1 st scalp

Out at ~ $3.40 Cheers.... Stay tuned ....this is a set up for a P.O ; )
Iseneschal - November 30, 2023

AMPE.....LoL...it took all but 10 mins to tank

All the Chasers were fried. Today being Thursday...you started out this a.m thinking its Friyay,,,,except it turned out to be Fryday
Iseneschal - November 30, 2023

AMPE....early a.m runner

Very thin float....under 500,000  post RS On watch
Iseneschal - November 30, 2023
View more Bullboard ››

Sky Gold Corp.

Sky Gold Corp.

Sky Gold Corp., a junior mineral exploration company, engages in the exploration and development of mineral properties in ...
View More »

Podcasts